Kyverna Therapeutics (KYTX) Institutional Ownership → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free KYTX Stock Alerts $13.23 +0.23 (+1.77%) (As of 05/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)CurrentInstitutional OwnershipPercentage18.08%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$178.64MNumber ofInstitutional Sellers(last 12 months)0 Get KYTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KYTX Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Kyverna Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/28/2024Teachers Retirement System of The State of Kentucky12,614$313K0.0%N/A0.029% 5/17/2024 Artal Group S.A.200,000$4.97M0.1%N/A0.464% 5/16/2024 Janus Henderson Group PLC606,500$15.04M0.0%N/A1.407% 5/16/2024 Bain Capital Life Sciences Investors LLC3,163,868$78.59M6.3%N/A7.338% 5/16/2024 Blackstone Inc.100,000$2.48M0.0%N/A0.232% 5/15/2024 Price T Rowe Associates Inc. MD929,634$23.09M0.0%N/A2.156% 5/15/2024 Avoro Capital Advisors LLC475,000$11.80M0.1%N/A1.102% 5/14/2024 StemPoint Capital LP41,000$1.02M0.3%N/A0.095% 5/10/2024 Vanguard Group Inc.264,215$6.56M0.0%N/A0.613% 5/2/2024 Jennison Associates LLC1,398,659$34.74M0.0%N/A3.244% (Data available from 1/1/2016 forward) KYTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KYTX shares? During the previous two years, 10 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($78.59M), Jennison Associates LLC ($34.74M), Price T Rowe Associates Inc. MD ($23.09M), Janus Henderson Group PLC ($15.04M), Avoro Capital Advisors LLC ($11.80M), Vanguard Group Inc. ($6.56M), and Artal Group S.A. ($4.97M).Learn more on KYTX's institutional investors. What percentage of Kyverna Therapeutics stock is owned by institutional investors? 18.08% of Kyverna Therapeutics stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings. Which institutional investors have been buying Kyverna Therapeutics stock? Of the 10 institutional investors that purchased Kyverna Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bain Capital Life Sciences Investors LLC ($3.16M), Jennison Associates LLC ($1.40M), Price T Rowe Associates Inc. MD ($929.63K), Janus Henderson Group PLC ($606.50K), Avoro Capital Advisors LLC ($475K), Vanguard Group Inc. ($264.22K), and Artal Group S.A. ($200K). How much institutional buying is happening at Kyverna Therapeutics? Institutional investors have bought a total of 7,191,490 shares in the last 24 months. This purchase volume represents approximately $178.64M in transactions. Related Companies: CABA Major Shareholders EXAI Major Shareholders VALN Major Shareholders ALEC Major Shareholders ADPT Major Shareholders TCRX Major Shareholders LXEO Major Shareholders EDIT Major Shareholders ALLO Major Shareholders VYGR Major Shareholders This page (NASDAQ:KYTX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.